Brevan Howard Capital Management’s CareDx CDNA Stock Holding History

Brevan Howard Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,604	Closed	-$306K	–	2132
2026 Q1	$306K	Sell	17,604 -3,418	-16%	-$64.7K	﹤0.01%	1606
2025 Q4	$396K	Buy	+21,022	New	+$352K	﹤0.01%	1220
2024 Q4	–	Sell	-6,665	Closed	-$208K	–	1084
2024 Q3	$208K	Sell	6,665 -29,923	-82%	-$745K	﹤0.01%	983
2024 Q2	$568K	Buy	36,588 +25,087	+218%	+$303K	0.01%	559
2024 Q1	$122K	Sell	11,501 -31,951	-74%	-$320K	﹤0.01%	871
2023 Q4	$521K	Buy	+43,452	New	+$356K	0.01%	461

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brevan Howard Capital Management's CDNA Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of CareDx (CDNA) in Q2 2026, closing a stake of 17,604 shares — an estimated $306K sold.

Brevan Howard Capital Management first reported a position in CDNA in Q4 2023 and held it in 6 quarters. The position peaked at $568K in Q2 2024. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Brevan Howard Capital Management reported no remaining CareDx position as of Q2 2026 after selling out during the quarter.
Brevan Howard Capital Management sold 17,604 CareDx shares in Q2 2026, an estimated $306K.
Brevan Howard Capital Management first reported a position in CareDx in Q4 2023 and held it in 6 quarters.
Brevan Howard Capital Management's CareDx position peaked at $568K in Q2 2024.
227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.